Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

President Trump has placed an indefinite suspension on research grant reviews and travel at the National Institutes of Health ...

U.S. Rep. Don Beyer of Virginia led 89 of his colleagues in decrying attacks on the NIH that endanger vitally important medical research.

I’m a health researcher. NIH’s pause on research grants could have a devastating cost. This is a potentially devastating ...

Trump has frozen all travel and communications at the Department of Health and Human Services, including the CDC and the ...

There's widespread confusion and fear among scientists and doctors on the sprawling National Institutes of Health campus and ...

TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT. Dr. Cole. a Ph.

A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.